People
-
DPI developer Pulmatrix has hired Margaret Wasilewski as its Chief Medical Officer, the company said. Wasilewski most recently offered consulting services as President of ID Remedies, and her previous experience includes clinical development positions at… Read more . . .
-
The Journal of Aerosol Medicine and Pulmonary Drug Delivery, the official journal of the International Society for Aerosols in Medicine (ISAM), has announced that GSK VP US Medical and Therapy Head for Respiratory Thomas G.… Read more . . .
-
Gilbert Technologies, which is developing a soft mist inhaler device based on electrohydrodynamic atomization technology, announced that Scott Fleming will take on the role of Chief Commercial Officer. Fleming, who has been the company’s Technology… Read more . . .
-
CDMO Hovione has announced that Jean-Luc Herbeaux will succeed Guy Villax as CEO of Hovione as of April 1, 2022. Herbeaux joined Hovione as Chief Operating Officer in 2020 after having served in various executive… Read more . . .
-
Ethris GmbH said that it has closed a $26.3 million Series B financing round led by Laureus Capital, with proceeds earmarked for continued development of the company’s ETH47 and ETH42 inhaled mRNA based therapies, which… Read more . . .
-
The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) has announced that Kindeva Drug Delivery Global Respiratory Product Development Manager Mike Needham will serve as Vice Chair of the IPAC-RS board until June 1,… Read more . . .
-
ReCode Therapeutics, which recently raised $80 million for development of inhaled genetic therapies for cystic fibrosis and primary ciliary dyskinesia (PCD), has announced the appointment of former Theravance Biopharma executive Shehnaaz Suliman as CEO and… Read more . . .
-
RxPack, a new device company formed from a joint venture between Lindal and Coster in 2021, has announced the appointment of inhaler development specialist Alberto Colombo as Head of R&D and Customer Technical Support. Colombo… Read more . . .
-
DPI developer PureIMS has announced the appointment of Jaap Wieling as Chief Executive Officer (CEO), succeeding Bram Van Dijck. According to his LinkedIn page, Wieling founded or co-founded several biopharm companies, including Bioralix, BiosanaPharma, and… Read more . . .
-
Inhaled nitric oxide developer Beyond Air announced that pulmonologist Andrew Colin has been appointed as the company’s Chief Medical Officer, effective December 1, 2021. Colin, who was most recently Chief of the Division of Pediatric… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK